Immunic Management
Management criteria checks 3/4
Immunic's CEO is Daniel Vitt, appointed in Apr 2019, has a tenure of 5.33 years. total yearly compensation is $1.21M, comprised of 48.3% salary and 51.7% bonuses, including company stock and options. directly owns 0.42% of the company’s shares, worth $501.24K. The average tenure of the management team and the board of directors is 4.3 years and 3.8 years respectively.
Key information
Daniel Vitt
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 48.3% |
| CEO tenure | 5.3yrs |
| CEO ownership | 0.4% |
| Management average tenure | 4.3yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Here's Why We're A Bit Worried About Immunic's (NASDAQ:IMUX) Cash Burn Situation
Jan 22
Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely
Oct 13Will Immunic (NASDAQ:IMUX) Spend Its Cash Wisely?
Jun 27Immunic sinks ~74% after hours as phase 1b psoriasis trial fails to separate from placebo
Oct 20Immunic stock gains on $60M oversubscribed PIPE financing
Oct 10Immunic GAAP EPS of -$0.72 in-line
Aug 04Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely
Jul 27Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?
Apr 13Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?
Dec 24Here's Why We're Watching Immunic's (NASDAQ:IMUX) Cash Burn Situation
Aug 13We're Hopeful That Immunic (NASDAQ:IMUX) Will Use Its Cash Wisely
May 10Immunic EPS misses by $0.95
May 06Immunic EPS misses by $0.07
Nov 05Enrollment underway in Immunic's Phase 2 part of IMU-838 study in COVID-19
Nov 02Immunic (IMUX) Investor Presentation - Slideshow
Oct 31CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$95m |
| Mar 31 2024 | n/a | n/a | -US$98m |
| Dec 31 2023 | US$1m | US$585k | -US$94m |
| Sep 30 2023 | n/a | n/a | -US$129m |
| Jun 30 2023 | n/a | n/a | -US$127m |
| Mar 31 2023 | n/a | n/a | -US$125m |
| Dec 31 2022 | US$3m | US$520k | -US$120m |
| Sep 30 2022 | n/a | n/a | -US$85m |
| Jun 30 2022 | n/a | n/a | -US$83m |
| Mar 31 2022 | n/a | n/a | -US$79m |
| Dec 31 2021 | US$2m | US$399k | -US$93m |
| Sep 30 2021 | n/a | n/a | -US$83m |
| Jun 30 2021 | n/a | n/a | -US$77m |
| Mar 31 2021 | n/a | n/a | -US$70m |
| Dec 31 2020 | US$1m | US$381k | -US$44m |
| Sep 30 2020 | n/a | n/a | -US$41m |
| Jun 30 2020 | n/a | n/a | -US$36m |
| Mar 31 2020 | n/a | n/a | -US$39m |
| Dec 31 2019 | US$2m | US$202k | -US$35m |
Compensation vs Market: Daniel's total compensation ($USD1.21M) is above average for companies of similar size in the US market ($USD689.66K).
Compensation vs Earnings: Daniel's compensation has been consistent with company performance over the past year.
CEO
Daniel Vitt (56 yo)
5.3yrs
Tenure
US$1,211,839
Compensation
Dr. Daniel Vitt, PhD has been the Chief Executive Officer of Immunic, Inc. since April 2019 and also served as its President until July 12, 2024. He is also managing director of Immunic Research GmbH in Ha...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.6yrs | US$648.93k | 0.024% $ 29.3k | |
| CEO & Director | 5.3yrs | US$1.21m | 0.42% $ 501.2k | |
| Chief Financial Officer | 4.3yrs | US$702.21k | 0.028% $ 33.9k | |
| Chief Medical Officer | 8yrs | US$845.29k | 0.36% $ 427.9k | |
| COO & President | less than a year | no data | no data | |
| Chief Scientific Officer | 7.6yrs | no data | no data | |
| Head of Investor Relations & Communications | no data | no data | no data | |
| General Counsel | 3.2yrs | no data | no data | |
| Chief Business Officer | 2.8yrs | no data | no data | |
| Chief Development Officer | less than a year | no data | no data |
4.3yrs
Average Tenure
54.5yo
Average Age
Experienced Management: IMUX's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.6yrs | US$648.93k | 0.024% $ 29.3k | |
| CEO & Director | 5.3yrs | US$1.21m | 0.42% $ 501.2k | |
| Lead Independent Director | 4.8yrs | US$99.16k | 0.088% $ 105.9k | |
| Independent Director | 4.8yrs | US$75.97k | 0.088% $ 105.9k | |
| Independent Director | 5.3yrs | US$82.95k | 0.11% $ 133.0k | |
| Member of Scientific Medical Advisory Board | 3.8yrs | no data | no data | |
| Member of Scientific Medical Advisory Board | 3.8yrs | no data | no data | |
| Member of Scientific Medical Advisory Board | 3.8yrs | no data | no data | |
| Independent Director | 1.3yrs | US$95.70k | 0% $ 0 | |
| Director | less than a year | no data | no data | |
| Independent Director | 2.1yrs | US$79.67k | 0.041% $ 49.1k |
3.8yrs
Average Tenure
58.5yo
Average Age
Experienced Board: IMUX's board of directors are considered experienced (3.8 years average tenure).